InsidersTradesSigma
Browse the complete record of transactions filed by Pfost Dale R, Chief Executive Officer. Director active across 1 company, notably Chemomab Therapeutics Ltd.. In total, 1 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €7k. History available since 14 March 2022. The latest transaction was disclosed on 14 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Pfost Dale R is the Chief Executive Officer at Chemomab Therapeutics Ltd. He is responsible for the strategic direction of the company, overseeing operations and financial performance. His role is essential to ensure growth and profitability for Chemomab in the biotechnology sector.